CHRS Next Earnings Date Notes

— Coherus BioSciences (CHRS) is a biopharmaceutical company specializing in the development & commercialization of innovative immunotherapies, with a particular focus on oncology & biosimilars. The company’s portfolio includes FDA-approved products like UDENYCA—a biosimilar of Neulasta—and toripalimab, an anti-PD-1 antibody for cancer. For investors, the most relevant business metrics to track on earnings calls include total net product revenue, product-specific sales (especially for UDENYCA and any new launches like the Cimerli biosimilar), cash & equivalents, and operating expenses. Pay close attention to updates on pipeline progress, regulatory milestones, and market share capture in the competitive biosimilar landscape. Gross margin trends & guidance on future launches, especially in immuno-oncology, are also key for understanding the company’s long-term potential. Additionally, insight into partnerships, commercialization updates, and reimbursement dynamics can provide context for assessing the sustainability of revenue streams and the company’s growth prospects. The next projected earnings date for CHRS is 11/5/2026 after close (stay tuned for a confirmed earnings date once announced).

CHRS Next Earnings Date FAQ

On this page we presented the CHRS Next Earnings Date information for Coherus BioSciences along with recent past earnings dates. For Q2 of 2026, CHRS reported earnings of -0.190/share, with the earnings report taking place on 8/5/2026. For Q1 of 2026, CHRS reported earnings of -0.250/share, with the earnings report taking place on 5/11/2026. For Q4 of 2025, CHRS reported earnings of -0.340/share, with the earnings report taking place on 3/9/2026. For Q3 of 2025, CHRS reported earnings of -0.330/share, with the earnings report taking place on 11/6/2025. For Q2 of 2025, CHRS reported earnings of -0.340/share, with the earnings report taking place on 8/7/2025. Based on these past earnings dates, the projected next earnings date for CHRS is 11/5/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Coherus BioSciences. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Coherus BioSciences shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Coherus BioSciences next earnings dates as well as any other stock out there in our coverage universe, to see when the next CHRS earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up CHRS's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the CHRS next earnings date.